ibandronate [Bonviva/Boniva]
ML19937
Approved small_molecule completed
Quick answer
ibandronate [Bonviva/Boniva] for Post Menopausal Osteoporosis is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Post Menopausal Osteoporosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed